Skip to content
OpenCapital
Get started

GoodRx Holdings, Inc. GDRX EV / EBITDA

EV / EBITDA at other companies

CVS Health logo
CVS HealthCVS
9.2×+2.7×
Amazon logo
AmazonAMZN
16.3×-0.3×
Doximity logo
DoximityDOCS
17.9×-27.0×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
19×+3.3×
Cencora logo
CencoraCOR
18.6×+2.4×
Cardinal Health logo
Cardinal HealthCAH
16.9×+4.4×

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-44.5%
Enterprise value$1.24B-35.4%
P/E45.5×-13.8×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Calculated from GoodRx Holdings, Inc.’s reported figures.

enterprise value/ebitda=5.9×

Based on the most recent quarter.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s EV / EBITDA?
GoodRx Holdings, Inc. (GDRX) reported EV / EBITDA of 5.9× in Q1 2026.
How has GoodRx Holdings, Inc.'s EV / EBITDA changed year-over-year?
GoodRx Holdings, Inc.'s EV / EBITDA decreased by 51.8% year-over-year, from 12.4× to 5.9×.
What is the long-term trend for GoodRx Holdings, Inc.'s EV / EBITDA?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s EV / EBITDA has grown at a -60.2% compound annual growth rate (CAGR), from 277.7× to 7×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.